Search Our Scientific Publications & Authors

Publications
find publications by category +
Translate page:

Cutting seton versus decompression and drainage seton in the treatment of high complex anal fistula: a randomized controlled trial.

Authors:
Qiuxiang Yu Congcong Zhi Lansi Jia Hui Li

Sci Rep 2022 05 12;12(1):7838. Epub 2022 May 12.

Department of Proctology, China-Japan Friendship Hospital, No 2 Yinghua East Street, Chaoyang District, Beijing, 100029, China.

This study aimed to compare the efficacy between decompression and drainage seton (DADS) and cutting seton (CS) in the treatment of high complex anal fistula. Patients were randomly assigned 1:1 to DADS or CS group. The primary outcome was the rate of wound healing. Second outcomes included time taken to return to work, postoperative pain, the severity of fecal incontinence and other complications. A total of 120 patients with a mean age of 39 years were included. There was no significant difference in the rate of complete wound healing at 1 year. The mean time taken to return to work was 5 ± 2 days in DADS group, shorter than CS group (10 ± 3, p < 0.001). Mean vaizey incontinence score and the post-operation pain in DADS group was significantly lower than CS group. No significant difference was found between two groups in the incidence of complications. DADS is as effective as Cutting seton for the treatment of high complex anal fistula but is associated with less postoperative pain and better sphincter function preserving.

Download full-text PDF

 Source
http://dx.doi.org/10.1038/s41598-022-11712-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098520PMC
May 2022

Publication Analysis

Top Keywords

time return
8
drainage seton
8
anal fistula
8
dads group
8
complex anal
8
high complex
8
treatment high
8
seton treatment
8
cutting seton
8
wound healing
8
decompression drainage
8
return work
8
group primary
4
incontinence complications
4
patients randomly
4
randomly assigned
4
complications total
4
assigned dads
4
fistula patients
4
total 120
4

Keyword Occurance

Similar Publications

Magistral Compounding with 3D Printing: A Promising Way to Achieve Personalized Medicine.

Authors:
Netta Beer Susanne Kaae Natalja Genina Sofia Kälvemark Sporrong Teresa Leonardo Alves Joëlle Hoebert Marie Louise De Bruin Ingrid Hegger

Ther Innov Regul Sci 2022 Aug 9. Epub 2022 Aug 9.

Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.

Background: Magistral compounding has always been an integral part of pharmacy practice. The increasing demand worldwide for personalized drug treatments might be accommodated by an increase in magistral compounding. The new, flexible technology of 3D medicine printing could advance this process even further. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Joint address from the President and the Chief Executive Officer: It's Time to Return, Refocus, Refresh, and Reflect.

Authors:
Linda S Tyler Paul W Abramowitz

Am J Health Syst Pharm 2022 Aug 9. Epub 2022 Aug 9.

ASHP, Bethesda, MD, USA.

View Article and Full-Text PDF
August 2022
Similar Publications

'I was young, I wanted to return to sport, and re-ruptured my ACL' - young active female patients' voices on the experience of sustaining an ACL re-rupture, a qualitative study.

Authors:
Ramana Piussi Ferid Krupic David Sundemo Eleonor Svantesson Andreas Ivarsson Urban Johnson Kristian Samuelsson Eric Hamrin Senorski

BMC Musculoskelet Disord 2022 Aug 9;23(1):760. Epub 2022 Aug 9.

SportRehab Sports Medicine Clinic, Gothenburg, Sweden.

Background: Despite anterior cruciate ligament (ACL) re-ruptures being common, research on patient experiences after knee trauma has primarily focused on the time after primary ACL reconstruction. Integrating qualitative research and patient experiences can facilitate researchers and clinicians in understanding the burden of an ACL re-rupture. The aim of the study was to explore the experiences of an ACL re-rupture journey in young active females aiming to return to knee-strenuous sports after primary ACL reconstruction. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

The benefits of a percutaneous supplemental screw to reinforce the hinge of a medial open wedge tibial osteotomy.

Authors:
Hsuan-Hsiao Ma Philip Lobenhoffer Jesse Chieh-Szu Yang

Arch Orthop Trauma Surg 2022 Aug 8. Epub 2022 Aug 8.

Department of Orthopaedics and Traumatology, Taipei Veterans General Hospital, No. 201, Sec 2, Shi-Pai Road, Taipei, 112, Taiwan.

Introduction: Our earlier studies reported that an additional lag screw placed from the opposite side increases the stability of the fixation construct in medial open wedge high tibia osteotomy (MOWHTO). The aim of the study was to evaluate the clinical relevance of the use of a supplemental screw with immediate post-operative full weight-bearing and its benefits in terms of functional outcome, radiographic outcome and complications.

Materials And Methods: A retrospective study was performed comparing the historical cohort (MOWHTO without opposite screw) (group A) with the current cohort (MOWHTO with opposite screw) (group B). Read More

View Article and Full-Text PDF
August 2022
Similar Publications

[Impact of Home Return Assistance Service in Heart Failure (PRADO-IC) on the one year re-hospitalisation and mortality in a heart failure hospitalized population of patients].

Authors:
Philippe Abassade Léa Cohen Audrey Fels Gilles Chatellier Emmanuelle Sacco Hélène Beaussier Laetitia Fleury Michel Komajda Romain Cador

Ann Cardiol Angeiol (Paris) 2022 Aug 5. Epub 2022 Aug 5.

Service de Cardiologie, Groupe Hospitalier Paris Saint Joseph, 185 rue Raymond Losserand, 75014, Paris, France.

Introduction: Congestive heart failure (CHF) is associated with prolonged and recurrent hospitalizations; the prognosis remains poor. Since 2013, the Caisse Primaire d'Assurance Maladie (CPAM) has set up a support program PRADO-IC (support program for returning home after hospitalisation for heart failure). The aim of this study was to evaluate the impact of PRADO-IC on the heart failure readmission rate and death rate at one year. Read More

View Article and Full-Text PDF
August 2022
Similar Publications
}